Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Xfund is among the backers of a $17m round for ImmuneID, which has been set up to commercialise research from Harvard University and Johns Hopkins University.

Ensoma has emerged with $70m in series A financing to advance research from Fred Hutchinson and University of Washington.

Today's deal net contains news from Boston Metal, Evologic Therapeutics, Lilz, GaitQ, Hemerion Therapeutics and Rebrain.

Today's deal net contains news from Nexthink, Metalenz, Grapheal, CellulaRevolution and Astrata.

University of Zurich has generated 143 spinouts since 1999, 75 out of which were founded in the past decade.

Atalanta Therapeutics has launched out of UMass with $110m in combined series A and partnership funding to develop therapies for neurodegenerative diseases.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.